CN1C=C(C(N)=O)C2CC(O)[C@@](NC(=O)CS(N)(=O)=O)(C(=O)O)C2C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?